Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Investigation of H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

NCT06325696 is registered in ClinicalTrials.gov with National Institute of Environmental Health Sciences (NIEHS) as lead sponsor.

NCT NCT06325696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06325696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Investigation of H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Lead sponsor
National Institute of Environmental Health Sciences (NIEHS)
Phase
Phase 2
Overall status
Recruiting
Start date
May 5, 2025
Completion date
December 31, 2027
Enrollment
37 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic pulmonary fibrosis, interstitial lung disease, lung diseases, interstitial